Corvus Pharmaceuticals, Inc.
$14.16
-0.56 (-3.80%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +7.4%
- 3 Months
- +14.1%
- YTD
- +83.9%
- 1 Year
- +157.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 178.9%
- Largest decline max drawdown, since Aug 2025
- -56.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.03
Own CRVS?
See how CRVS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.